Table 1.
Survival time | |||||
---|---|---|---|---|---|
Patient characteristics | Total | t < 3 years | 3 ≤ t < 6 years | 6 ≤ t < 9 years | 9 ≤ t < 13 years |
(N = 18,667) | (N = 9121) | (N = 4515) | (N = 3565) | ||
n (%) | n (%) | n (%) | n (%) | n (%) | |
Age at diagnosis | |||||
<50 years | 5577 (16) | 2252 (12) | 1567 (17) | 934 (21) | 824 (23) |
50–59 years | 9956 (28) | 4657 (25) | 2746 (30) | 1370 (30) | 1182 (33) |
60–69 years | 9678 (27) | 5316 (28) | 2488 (27) | 1127 (25) | 747 (21) |
≥70 years | 10,657 (30) | 6441 (35) | 2320 (25) | 1084 (24) | 812 (23) |
Region of residence at diagnosisa | |||||
Northeast | 8767 (24) | 4449 (24) | 2313 (25) | 1139 (25) | 866 (24) |
Northwest | 2373 (7) | 1209 (6) | 631 (7) | 307 (7) | 226 (6) |
Southeast | 7081 (20) | 3829 (21) | 1759 (19) | 834 (18) | 659 (18) |
Southwest | 17,647 (49) | 9180 (49) | 4418 (48) | 2235 (50) | 1814 (51) |
Race/ethnicity | |||||
Non-Hispanic White | 25,430 (71) | 12,921 (69) | 6567 (72) | 3275 (73) | 2667 (75) |
Non-Hispanic Black | 2542 (7) | 1581 (8) | 565 (6) | 231 (5) | 165 (5) |
Non-Hispanic Asian/Pacific Islander | 3190 (9) | 1612 (8) | 800 (9) | 433 (10) | 345 (10) |
Non-Hispanic American Indian/Alaskan Native | 229 (1) | 122 (1) | 54 (1) | 28 (1) | 25 (1) |
Hispanic - all races | 4477 (12) | 2431 (13) | 1135 (12) | 548 (12) | 363 (10) |
Stage | |||||
Localized | 5764 (16) | 1936 (10) | 1400 (15) | 1174 (26) | 1254 (35) |
Regional | 7802 (22) | 3088 (17) | 2114 (23) | 1395 (31) | 1205 (34) |
Distant | 22,302 (62) | 13,643 (73) | 5607 (61) | 1946 (43) | 1106 (31) |
Histotype | |||||
High-grade serous | 24,004 (67) | 13,683 (73) | 6281 (69) | 2495 (55) | 1545 (43) |
Low-grade serous | 768 (2) | 245 (1) | 230 (3) | 160 (4) | 133 (4) |
Endometrioid | 5015 (14) | 1779 (10) | 1294 (14) | 982 (22) | 960 (27) |
Clear cell | 3098 (9) | 1506 (8) | 713 (8) | 428 (9) | 451 (13) |
Mutinous | 2983 (8) | 1454 (8) | 603 (7) | 450 (10) | 476 (13) |
Marital status at diagnosis | |||||
Married | 19,950 (56) | 9765 (52) | 5332 (58) | 2700 (60) | 2153 (60) |
Never married | 7129 (20) | 3738 (20) | 1727 (19) | 917 (20) | 747 (21) |
Widowed | 4448 (12) | 2776 (15) | 963 (11) | 417 (9) | 292 (8) |
Separated/divorced | 4341 (12) | 2388 (13) | 1099 (12) | 481 (11) | 373 (11) |
Surgery of primary site | |||||
No | 2945 (8) | 2631 (14) | 222 (2) | 61 (1) | 31 (1) |
Yes | 32,923 (92) | 16,036 (86) | 8899 (98) | 4454 (99) | 3534 (99) |
Insurance status at diagnosisb | |||||
Insured | 23,427 (83) | 12,850 (82) | 6504 (85) | 3351 (87) | 722 (87) |
Uninsured | 1040 (4) | 535 (3) | 317 (4) | 153 (4) | 35 (4) |
Medicaid | 3360 (12) | 2183 (14) | 799 (10) | 314 (8) | 64 (8) |
Unknown | 279 (1) | 170 (1) | 65 (1) | 35 (1) | 9 (1) |
Cause of deathc | |||||
Death due to ovarian cancer | 14,906 (90) | 9928 (92) | 3887 (89) | 884 (78) | 207 (65) |
Death due to other causes | 1524 (9) | 778 (7) | 414 (10) | 226 (20) | 106 (33) |
Unknown | 205 (1) | 120 (1) | 58 (1) | 22 (2) | 5 (2) |
SEER: Surveillance, Epidemiology, and End Results.
Northeast includes Michigan, Iowa, New Jersey, and Connecticut; Northwest includes Washington and Alaska; Southeast includes Georgia, Kentucky, and Louisiana; Southwest includes California, Hawaii, New Mexico, and Utah.
Insurance status was available for cases diagnosed in 2007 and later. Statistics provided for cases diagnosed in 2007 and later (n = 28,106).
Restricted to women who died during the follow-up period (n = 16,635).